نتائج البحث - "O. V. Vorob'eva"

المصدر: Neurology, Neuropsychiatry, Psychosomatics; Vol 16, No 3 (2024); 12-18 ; Неврология, нейропсихиатрия, психосоматика; Vol 16, No 3 (2024); 12-18 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2024-3

مصطلحات موضوعية: long COVID, atrial fibrillation, vascular risk factors, фибрилляция предсердий, сосудистые факторы риска

وصف الملف: application/pdf

العلاقة: https://nnp.ima-press.net/nnp/article/view/2273/1660Test; Остроумова ОД, Кочетков АИ, Остроумова ТМ. Фибрилляция предсердий и когнитивные нарушения: распространенность и патогенетические механизмы взаимосвязи (часть 1). Неврология, нейропсихиатрия, психосоматика. 2020;12(3):105-10. doi:10.14412/2074-27112020-3-105-110; Sachdev PS, Lipnicki DM, Kochan NA, et al. The prevalence of mild cognitive impairment in diverse geographical and ethnocultural regions: the COSMIC collaboration. PLoS One. 2015;10(11):e0142388. doi:10.1371/journal.pone.0142388; Lopez OL, Kuller LH, Becker JT, et al. Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study. Arch Neurol. 2007;64(3):416-20. doi:10.1001/archneur.64.3.416; Крупенин ПМ, Воскресенская ОН, Напалков ДА и др. Когнитивные нарушения и болезнь мелких сосудов при фибрилляции предсердий. Неврология, нейропсихиатрия, психосоматика. 2022;14(6):55-62. doi:10.14412/2074-2711-2022-6-55-62; Zuin M, Roncon L, Passaro A, et al. Risk of dementia in patients with atrial fibrillation: Short versus long follow-up. A systematic review and meta-analysis. Int J Geriatr Psychiatry. 2021;36(10):1488-500. doi:10.1002/gps.5582 . Epub 2021 May 27.; Парфенов ВА. Когнитивные нарушения у пациентов с фибрилляцией предсердий. Consilium Medicum. 2023;25(2):81-5. doi:10.26442/20751753.2023.2.202220; WHO coronavirus disease (COVID-19) dashboard. Available at: https://covid19.who.intTest/ (accessed 04.03.2024).; Боголепова АН, Коваленко ЕА, Махнович ЕВ идр. Когнитивные нарушения после COVID-19: отдаленные последствия. Эффективная фармакотерапия. 2022;18(26):24-30. doi:10.33978/23073586-2022-18-26-24-30; Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258-63. doi:10.1016/j.cmi.2020.09.052. Epub 2020 Oct 5.; Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020 Dec 11;15(12):e0243882. doi:10.1371/journal.pone.0243882; Aiyegbusi OL, Hughes SE, Turner G, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428-42. doi:10.1177/01410768211032850. Epub 2021 Jul 15.; Terlecki M, Wojciechowska W, Klocek M, et al. Prevalence and clinical implications of atrial fibrillation in patients hospitalized due to COVID-19: Data from a registry in Poland. Front Cardiovasc Med. 2023 Mar 13:10:1133373. doi:10.3389/fcvm.2023.1133373. eCollection 2023.; Воробьева ОВ. Аффективные нарушения у пациентов с церебральной микроангиопатией в период пандемии COVID-19. РМЖ. 2021;(5):35-41.; El-Arif G, Farhat A, Khazaal S, et al. The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19. Molecules. 2021 Nov 17;26(22):6945. doi:10.3390/molecules26226945; Coto E, Avanzas P, Gomez J. The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019. Eur Cardiol. 2021 Mar 9:16:e07. doi:10.15420/ecr.2020.30. eCollection 2021 Feb.; Scutelnic A, Heldner MR. Vascular Events, Vascular Disease and Vascular Risk Factors-Strongly Intertwined with COVID-19. Curr Treat Options Neurol. 2020;22(11):40. doi:10.1007/s11940-020-00648-y. Epub 2020 Oct 8.; Chung MK, Zidar DA, Bristow MR, et al. COVID-19 and Cardiovascular Disease: From Bench to Bedside. Circ Res. 2021;128(8):1214-36. doi:10.1161/CIRCRESAHA.121.317997; Воробьева ОВ. Церебральная микроангиопатия, ассоциированная с артериальной гипертензией и метаболическими нарушениями. Эффективная фармакотерапия. 2020;3(20):62-9.; Крупенин ПМ, Перепелов ВА, Перепелова ЕМ идр. Компьютерный анализ данных магнитно-резонансной томографии головного мозга в верификации болезни мелких сосудов и умеренного когнитивного расстройства. Consilium Medicum. 2022;24(2):90-5. doi:10.26442/20751753.2022.2.201353; Owens CD, Pinto CB, Detwiler S, et al. Cerebral small vessel disease pathology in COVID-19 patients: A systematic review. Ageing Res Rev. 2023 Jul:88:101962. doi:10.1016/j.arr.2023.101962. Epub 2023 May 22.; Sachdev P, Kalaria R, O'Brien J, et al; Internationlal Society for Vascular Behavioral and Cognitive Disorders. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):206-18. doi:10.1097/WAD.0000000000000034; Julayanont P, Brousseau M, Chertkow H, et al. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease. J Am Geriatr Soc. 2014 Apr;62(4):679-84. doi:10.1111/jgs.12742. Epub 2014 Mar 17.; Ciceri F, Beretta L, Scandroglio AM, et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 2020 Apr 15;22(2):95-7. doi:10.51893/2020.2.pov2. Epub ahead of print.; Woo MS, Malsy J, Pottgen J, et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020 Nov 23;2(2):fcaa205. doi:10.1093/brain-comms/fcaa205; Головачева ВА, Табеева ГР, Кузнецов ИВ. Когнитивные нарушения при COVID-19: взаимосвязь, патогенез и вопросы терапии. Неврология, нейропсихиатрия, психосоматика. 2021;13(2):123-9. doi:10.14412/2074-2711-2021-2-123-129; Moretta P, Ambrosino P, Lanzillo A, et al. Cognitive Impairment in Convalescent COVID-19 Patients Undergoing Multidisciplinary Rehabilitation: The Association with the Clinical and Functional Status. Healthcare (Basel). 2022 Mar 4;10(3):480. doi:10.3390/healthcare10030480; Palta P, Albert MS, Gottesman RF. Heart health meets cognitive health: evidence on the role of blood pressure. Lancet Neurol. 2021 Oct;20(10):854-67. doi:10.1016/S1474-4422(21)00248-9; https://nnp.ima-press.net/nnp/article/view/2273Test

الإتاحة: https://doi.org/10.14412/2074-2711-2024-3-12-1810.14412/2074-2711-2024-310.14412/2074-27112020-3-105-11010.1371/journal.pone.014238810.1001/archneur.64.3.41610.14412/2074-2711-2022-6-55-6210.1002/gps.558210.26442/20751753.2023.2.20222010.33978/23073586-2022-18-26-24-3010.1016/j.cmi.2020.09.05210.1371/journal.pone.024388210.1177/0141076821103285010.3389/fcvm.2023.113337310.3390/molecules2622694510.15420/ecr.2020.3010.1007/s11940-020-00648-y10.1161/CIRCRESAHA.121.31799710.26442/20751753.2022.2.20135310.1016/j.arr.2023.10196210.1097/WAD.000000000000003410.1111/jgs.1274210.51893/2020.2.pov210.1093/brain-comms/fcaa20510.14412/2074-2711-2021-2-123-12910.3390/healthcare1003048010.1016/S1474-4422Test(21)00248-9
https://nnp.ima-press.net/nnp/article/view/2273Test

View record in BASE

7

دورية أكاديمية

Effect of dopaminergic therapy on lacrimation in Parkinson's disease ; Влияние дофаминергической терапии на слезоотделение при болезни Паркинсона

المؤلفون: A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov, A. V. Kuchuk, А. А. Пилипович, О. В. Воробьева, С. А. Макаров, А. В. Кучук

المساهمون: The investigation has not been sponsored, Исследование не имело спонсорской поддержки

المصدر: Neurology, Neuropsychiatry, Psychosomatics; Vol 15, No 6 (2023); 32-39 ; Неврология, нейропсихиатрия, психосоматика; Vol 15, No 6 (2023); 32-39 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2023-6

مصطلحات موضوعية: леводопа, non-motor disorders, autonomic dysfunction, lacrimation, gastrointestinal dysfunction, amantadine, levodopa, немоторные нарушения, вегетативные нарушения, слезоотделение, желудочно-кишечная дисфункция, амантадин

وصف الملف: application/pdf

العلاقة: https://nnp.ima-press.net/nnp/article/view/2136/1603Test; Chrysou A, Jansonius NM, van Laar T. Retinal layers in Parkinson's disease: A metaanalysis of spectral-domain optical coherence tomography studies. Parkinsonism Relat Disord. 2019 Jul;64:40-9. doi:10.1016/j.parkreldis.2019.04.023. Epub 2019 Apr 30.; Катунина ЕА, Залялова ЗА, Похабов ДВ и др. Болезнь Паркинсона. Фокус на ранние стадии. Неврология, нейропсихиатрия, психосоматика. 2023;15(3):95-103. doi:10.14412/2074-2711-2023-3-95-103; Armstrong RA. Visual Dysfunction in Parkinson's Disease. Int Rev Neurobiol. 2017;134:921-46. doi:10.1016/bs.irn.2017.04.007. Epub 2017 May 31.; Visser F, Vlaar AMM, Borm CDJM, et al. Diplopia in Parkinson's disease: visual illusion or oculomotor impairment? J Neurol. 2019 Oct;266(10):2457-64. doi:10.1007/s00415-01909430-w. Epub 2019 Jun 18.; Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012 May;96(5):614-8. doi:10.1136/bjophthalmol-2011-300539. Epub 2011 Dec 1.; Borm CDJM, Werkmann M, de Graaf D, et al. Undetected ophthalmological disorders in Parkinson's disease. J Neurol. 2022 Jul;269(7):3821-32. doi:10.1007/s00415-02211014-0. Epub 2022 Mar 9.; Никитина АЮ, Мельникова НВ, Мошетова ЛК, Левин ОС. Зрительные нарушения при болезни Паркинсона. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2022;122(11-2):5-11. doi:10.17116/jnevro20221221125; Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017 Jul;15(3):334-65. doi:10.1016/j.jtos.2017.05.003. Epub 2017 Jul 20.; Inomata T, Shiang T, Iwagami M, et al. Changes in Distribution of Dry Eye Disease by the New 2016 Diagnostic Criteria from the Asia Dry Eye Society. Sci Rep. 2018 Jan 30;8(1):1918. doi:10.1038/s41598-018-19775-3. Erratum in: Sci Rep. 2018 Jul 4;8(1):10368.; Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf. 2017 Jul;15(3):276-83. doi:10.1016/j.jtos.2017.05.008. Epub 2017 Jul 20.; Belmonte C, Nichols JJ, Cox SM, et al. TFOS DEWS II pain and sensation report. Ocul Surf. 2017 Jul;15(3):404-37. doi:10.1016/j.jtos.2017.05.002. Epub 2017 Jul 20.; Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017 Jul;15(3):438-510. doi:10.1016/j.jtos.2017.05.011. Epub 2017 Jul 20. Erratum in: Ocul Surf. 2019 Oct;17(4):842.; Willcox MDP, Argüeso P, Georgiev GA, et al. TFOS DEWS II Tear Film Report. Ocul Surf. 2017 Jul;15(3):366-403. doi:10.1016/j.jtos.2017.03.006. Epub 2017 Jul 20.; Sescousse G, Ligneul R, van Holst RJ, et al. Spontaneous eye blink rate and dopamine synthesis capacity: preliminary evidence for an absence of positive correlation. Eur J Neurosci. 2018 May;47(9):1081-6. doi:10.1111/ejn.13895. Epub 2018 Mar 26.; Hamedani AG, Gold DR. Eyelid Dysfunction in Neurodegenerative, Neurogenetic, and Neurometabolic Disease. Front Neurol. 2017 Jul 18;8:329. doi:10.3389/fneur.2017.00329; Nowacka B, Lubinski W, Honczarenko K, et al. Ophthalmological features of Parkinson disease. Med Sci Monit. 2014 Nov 11;20:2243-9. doi:10.12659/MSM.890861; Davies K, Ng WF. Autonomic Nervous System Dysfunction in Primary Sjögren's Syndrome. Front Immunol. 2021 Jul 26;12:702505. doi:10.3389/fimmu.2021.702505; Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease. Acta Neuropathol. 2010 Jun;119(6):703-13. doi:10.1007/s00401-0100665-2. Epub 2010 Mar 14.; Wakabayashi K, Mori F, Tanji K, et al. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol. 2010 Jul;120(1):1-12. doi:10.1007/s00401-010-0706-x. Epub 2010 Jun 9.; Leclair-Visonneau L, Clairembault T, Volteau C, et al. Colonic neuropathology is not associated with autonomic dysfunction in Parkinson's disease. Parkinsonism Relat Disord. 2019 Apr;61:224-7. doi:10.1016/j.parkreldis.2018.09.021. Epub 2018 Sep 18.; Leclair-Visonneau L, Magy L, Volteau C, et al. Heterogeneous pattern of autonomic dysfunction in Parkinson's disease. J Neurol. 2018 Apr;265(4):933-41. doi:10.1007/s00415018-8789-8. Epub 2018 Feb 20.; Ekker MS, Janssen S, Seppi K, et al. Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked. Parkinsonism Relat Disord. 2017 Jul;40:1-10. doi:10.1016/j.parkreldis.2017.02.014. Epub 2017 Feb 21.; Nagino K, Sung J, Oyama G, et al. Prevalence and characteristics of dry eye disease in Parkinson's disease: a systematic review and meta-analysis. Sci Rep. 2022 Nov 1;12(1):18348. doi:10.1038/s41598-022-22037-y; Reddy VC, Patel SV, Hodge DO, Leavitt JA. Corneal sensitivity, blink rate, and corneal nerve density in progressive supranuclear palsy and Parkinson disease. Cornea. 2013 May;32(5):631-5. doi:10.1097/ICO.0b013e3182574ade; Örnek N, Dag E, Örnek K. Corneal sensitivity and tear function in neurodegenerative diseases. Curr Eye Res. 2015 Apr;40(4):423-8. doi:10.3109/02713683.2014.930154. Epub 2014 Jun 23.; Chou R, Dana T, Bougatsos C, et al. Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016 Mar 1;315(9):915-33. doi:10.1001/jama.2016.0783; Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, et al. The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord. 2010 Apr 30;25(6):704-9. doi:10.1002/mds.22868; Ахмадеева ГН, Магжанов РВ, Таюпова ГН, Байтимеров АР. Клинические особенности, диагностика и лечение когнитивных расстройств при болезни Паркинсона. Неврология, нейропсихиатрия, психосоматика. 2017;9(1):101-5. doi:10.14412/20742711-2017-1-101-105; Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52. doi:10.1136/jnnp.51.6.745; Stevens S. Schirmer's test. Community Eye Health. 2011 Dec;24(76):45.; Jenkinson C, Fitzpatrick R, Peto V, et al. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing. 1997 Sep;26(5):353-7. doi:10.1093/ageing/26.5.353; Hagell P, Nygren C. The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine. J Neurol Neurosurg Psychiatry. 2007 Nov;78(11):1191-8. doi:10.1136/jnnp.2006.111161. Epub 2007 Apr 18.; Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord. 2006 Jul;21(7):916-23. doi:10.1002/mds.20844; Dimenäs E, Carlsson G, Glise H, et al. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl. 1996;221:8-13. doi:10.3109/00365529609095544; Kulich KR, Madisch A, Pacini F, et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes. 2008 Jan 31;6:12. doi:10.1186/1477-7525-6-12; Новик АА, Ионова ТИ. Руководство по исследованию качества жизни в медицине. Москва: ОЛМА Медиа Групп; 2007. 320 с.; Комарова КВ, Раткина НН, Поленичкин ВК. Способ оценки секреторной функции слюнных желез. Казанский медицинский журнал. 2013;94(2):245-6. doi:10.17816/KMJ1597; Еловикова ТМ, Григорьев СС. Слюна как биологическая жидкость и ее роль в здоровье полости рта: Учебное пособие. Екатеринбург: Издательский Дом «ТИРАЖ»; 2018. 136 с. Доступно по ссылке: https://dentalpress.ru/upload/dba7d3f2bf9300098986b1c541dec8b5/files/d19e1d3e7ce3527b20c2abfda3b58deTest b.pdf (дата обращения 19.08.2022).; Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997 Sep;32(9):920-4. doi:10.3109/00365529709011203; O'Leary MP, Barry MJ, Fowler FJ Jr. Hard measures of subjective outcomes: validating symptom indexes in urology. J Urol. 1992 Nov;148(5):1546-8; discussion 1564. doi:10.1016/s0022-5347(17)36965-3; Аляева ЮГ, редактор. Болезни предстательной железы. Москва: ГЭОТАР-Медиа; 2009. 240 с. Доступно по ссылке: https://medknigaservis.ru/wp-content/uploads/2019/01/Q0008940.pdfTest; Lemack GE, Dewey RB Jr, Roehrborn CG, et al. Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson's disease. Urology. 2000 Aug 1;56(2):250-4. doi:10.1016/s00904295(00)00641-5; Ulusoy EK, Ulusoy DM. Evaluation of corneal sublayers thickness and corneal parameters in patients with Parkinson's disease. Int J Neurosci. 2021 Oct;131(10):939-45. doi:10.1080/00207454.2020.1761353. Epub 2020 May 4.; Sögütlü Sari E, Koc R, Yazici A, et al. Tear Osmolarity, Break-up Time and Schirmer's Scores in Parkinson's Disease. Turk J Ophthalmol. 2015 Aug;45(4):142-5. doi:10.4274/tjo.46547. Epub 2015 Aug 5.; Agostino R, Bologna M, Dinapoli L, et al. Voluntary, spontaneous, and reflex blinking in Parkinson's disease. Mov Disord. 2008 Apr 15;23(5):669-75. doi:10.1002/mds.21887; Tamer C, Melek IM, Duman T, Oksüz H. Tear film tests in Parkinson's disease patients. Ophthalmology. 2005 Oct;112(10):1795. doi:10.1016/j.ophtha.2005.04.025; Aksoy D, Ortak H, Kurt S, et al. Central corneal thickness and its relationship to Parkinson's disease severity. Can J Ophthalmol. 2014 Apr;49(2):152-6. doi:10.1016/j.jcjo.2013.12.010; Ponirakis G, Al Hamad H, Sankaranarayanan A, et al. Association of corneal nerve fiber measures with cognitive function in dementia. Ann Clin Transl Neurol. 2019 Mar 2;6(4):689-97. doi:10.1002/acn3.746; Pavlenko TA, Chesnokova NB, Nodel MR, et al. Molecular Mechanisms and Clinical Manifestations of Catecholamine Dysfunction in the Eye in Parkinson's Disease As a Basis for Developing Early Diagnosis. Acta Naturae. 2020 Apr-Jun;12(2):52-62. doi:10.32607/actanaturae.10906; Srivanitchapoom P, Pandey S, Hallett M. Drooling in Parkinson’s disease: A review. Parkinsonism Relat Disord. 2014;20:1109-18. doi:10.1016/j.parkreldis.2014.08.013; Пилипович АА, Воробьева ОВ. Дисфункция верхних отделов желудочнокишечного тракта у пациентов на I—III стадиях болезни Паркинсона и ее коррекция агонистами дофаминовых рецепторов. Журнал неврологии и психиатрии им. С.С. Корсакова. 2022;122(11):86-93. doi:10.17116/jnevro202212211186; Брсикян ЛА, Полуэктова ЕА, Полуэктов МГ. Состояние микробиома кишечника как фактор развития болезни Паркинсона. Неврология, нейропсихиатрия, психосоматика. 2023;15(1):90-6. doi:10.14412/2074-2711-2023-1-90-96; https://nnp.ima-press.net/nnp/article/view/2136Test

View record in BASE

8

دورية أكاديمية

Influence of premorbid psychosocial stressors on chronic localized pain syndromes clinical characteristics (observational study) ; Влияние преморбидных психосоциальных стрессоров на клинические характеристики хронических локализованных болевых синдромов (обсервационное исследование)

المؤلفون: A. A. Gertsog, O. V. Vorob’eva, T. E. Morozova, A. G. Reze, T. V. Zaugolnikova, E. O. Samokhina, А. А. Герцог, О. В. Воробьева, Т. Е. Морозова, А. Г. Резе, Т. В. Заугольникова, Е. О. Самохина

المصدر: Meditsinskiy sovet = Medical Council; № 3 (2023); 52-60 ; Медицинский Совет; № 3 (2023); 52-60 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: психологические факторы, pain syndrome, psychosocial stressors, distress, somatic factors, psychological factors, болевой синдром, психосоциальные стрессоры, дистресс, соматические факторы

وصف الملف: application/pdf

العلاقة: https://www.med-sovet.pro/jour/article/view/7412/6605Test; Elzahaf R.A., Tashani O.A., Unsworth B.A., Johnson M.I. The prevalence of chronic pain with an analysis of countries with a Human Development Index less than 0.9: a systematic review without meta-analysis. Curr Med Res Opin. 2012;28(7):1221–1229. https://doi.org/10.1185/03007995.2012.703132Test.; Яхно Н.Н., Кукушкин М.Л. Хроническая боль: медико-биологические и социально-экономические аспекты. Вестник Российской академии медицинских наук. 2012;67(9):54–58. https://doi.org/10.15690/vramn.v67i9.407Test.; Luppino F.S., de Wit L.M., Bouvy P.F., Stijnen T., Cuijpers P., Penninx B.W.J.H., Zitman F.G. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220–229. https://doi.org/10.1001/archgenpsychiatry.2010.2Test.; Осипова Н.А., Петрова В.В. Типы боли и основные группы антиноцицептивных средств. Регионарная анестезия и лечение острой боли. 2013;7(1):38–43. Режим доступа: https://cyberleninka.ru/article/n/tipy-boli-i-osnovnye-gruppy-antinotsitseptivnyh-sredstvTest.; Данилов А.Б. Нейропатическая боль. Клиническая геронтология. 2007;13(2):27–36. Режим доступа: https://cyberleninka.ru/article/n/neyropaticheskaya-bolTest.; Kraepelien M., Blom K., Forsell E., Hentati Isacsson N., Bjurner P., Morin C.M. et al. A very brief self-report scale for measuring insomnia severity using two items from the Insomnia Severity Index development and validation in a clinical population. Sleep Med. 2021;(81):365–374. https://doi.org/10.1016/j.sleep.2021.03.003Test.; Wu Y., Levis B., Sun Y., He C., Krishnan A., Neupane D. et al. Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis. BMJ. 2021;373:n972. https://doi.org/10.1136/bmj.n972Test.; Hendriks C., Drent M., Elfferich M., De Vries J. The Fatigue Assessment Scale: quality and availability in sarcoidosis and other diseases. Curr Opin Pulm Med. 2018;24(5):495–503. https://doi.org/10.1097/MCP.0000000000000496Test.; Machado M.O., Kang N.C., Tai F., Sambhi R.D.S., Berk M., Carvalho A.F. et al. Measuring fatigue: a meta-review. Int J Dermatol. 2021;60(9):1053–1069. https://doi.org/10.1111/ijd.15341Test.; Omelyanovskiy V., Musina N., Ratushnyak S., Bezdenezhnykh T., Fediaeva V., Roudijk B., Purba F.D. Valuation of the EQ-5D-3L in Russia. Qual Life Res. 2021;30(7):1997–2007. https://doi.org/10.1007/s11136-021-02804-6Test.; Linton S.J., Shaw W.S. Impact of Psychological Factors in the Experience of Pain. Physical Therapy. 2011;91(5):700–711. https://doi.org/10.2522/ptj.20100330Test.; Hurley R.W., Adams M.C. Sex, gender, and pain: an overview of a complex field. Anesth Analg. 2008;107(1):309–317. https://doi.org/10.1213/01.ane.0b013e31816ba437Test.; Keogh E., McCracken L.M., Eccleston C. Do men and women differ in their response to interdisciplinary chronic pain management? Pain. 2005;114(1–2):37–46. https://doi.org/10.1016/j.pain.2004.12.009Test.; Palmeira C.C., Ashmawi H.A., Posso Ide P. Sex and pain perception and analgesia. Rev Bras Anestesiol. 2011;61(6):814–828. https://doi.org/10.1016/S0034-7094Test(11)70091-5.; Meng W., Deshmukh H.A., Donnelly L.A. Wellcome Trust Case Control Consortium 2 (WTCCC2); Surrogate markers for Microand Macro-vascular hard endpoints for Innovative diabetes Tools (SUMMIT) study group, Torrance N., Colhoun H.M., Palmer C.N., Smith B.H. A Genome-wide Association Study Provides Evidence of Sex-specific Involvement of Chr1p35.1 (ZSCAN20-TLR12P) and Chr8p23.1 (HMGB1P46) With Diabetic Neuropathic Pain. EBioMedicine. 2015;2(10):1386–1393. https://doi.org/10.1016/j.ebiom.2015.08.001Test.; Craft R.M. Modulation of pain by estrogens. Pain. 2007;132(1):S3-S12. https://doi.org/10.1016/j.pain.2007.09.028Test.; Martínez-Martínez L.A., Mora T., Vargas A., Fuentes-Iniestra M., Martínez-Lavín M. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies. J Clin Rheumatol. 2014;20(3):146–150. https://doi.org/10.1097/RHU.0000000000000089Test.; Lindell M., Grimby-Ekman A. Stress, non-restorative sleep, and physical inactivity as risk factors for chronic pain in young adults: A cohort study. PLoS One. 2022;17(1):e0262601. https://doi.org/10.1371/journal.pone.0262601Test.; Eisenlohr-Moul T.A., Crofford L.J., Howard T.W., Yepes J.F., Carlson C.R., de Leeuw R. Parasympathetic reactivity in fibromyalgia and temporomandibular disorder: associations with sleep problems, symptom severity, and functional impairment. J Pain. 2015;16(3):247–257. https://doi.org/10.1016/j.jpain.2014.12.005Test.; Martínez-Lavín M. Fibromyalgia in women: somatisation or stress-evoked, sex-dimorphic neuropathic pain? Clin Exp Rheumatol. 2021;39(2):422–425. https://doi.org/10.55563/clinexprheumatol/0c7d6vTest.; Gupta A., Silman A.J., Ray D., Morriss R., Dickens C., MacFarlane G.J., Chiu Y.H., Nicholl B., McBeth J. The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study. Rheumatology (Oxford). 2007;46(4):666–671. https://doi.org/10.1093/rheumatology/kel363Test.; Queiroz L.P., Peres M.F., Piovesan E.J., Kowacs F., Ciciarelli M.C., Souza J.A., Zukerman E. A nationwide population-based study of tension-type headache in Brazil. Headache. 2009;49(1):71–78. https://doi.org/10.1111/j.1526-4610.2008.01227.xTest.; Russell M.B., Levi N., Saltyte-Benth J., Fenger K. Tension-type headache in adolescents and adults: a population based study of 33,764 twins. Eur J Epidemiol. 2006;21(2):153–160. https://doi.org/10.1007/s10654-0056031-3Test.; McCracken L.M., Eccleston C. Coping or acceptance: what to do about chronic pain? Pain. 2003;105(1–2):197–204. https://doi.org/10.1016/s0304-3959Test(03)00202-1.; Bernal-Utrera C., Gonzalez-Gerez J.J., Anarte-Lazo E., Rodriguez-Blanco C. Manual therapy versus therapeutic exercise in non-specific chronic neck pain: a randomized controlled trial. Trials. 2020;21(1):682. https://doi.org/10.1186/s13063-020-04610-wTest.; Rodero B., Casanueva B., Luciano J.V., Gili M., Serrano-Blanco A., García-Campayo J. Relationship between behavioural coping strategies and acceptance in patients with fibromyalgia syndrome: elucidating targets of interventions. BMC Musculoskelet Disord. 2011;(12):143. https://doi.org/10.1186/1471-2474-12-143Test.; Geneen L.J., Moore R.A., Clarke C., Martin D., Colvin L.A., Smith B.H. Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017;4(4):CD011279. https://doi.org/10.1002/14651858.CD011279.pub3Test.; Sisignano M., Parnham M.J., Geisslinger G. Novel Approaches to Persistent Pain Therapy. Trends Pharmacol Sci. 2019;40(6):367–377. https://doi.org/10.1016/j.tips.2019.04.003Test.; https://www.med-sovet.pro/jour/article/view/7412Test

الإتاحة: https://doi.org/10.21518/ms2022-028Test
https://doi.org/10.1185/03007995.2012.703132Test
https://doi.org/10.15690/vramn.v67i9.407Test
https://doi.org/10.1001/archgenpsychiatry.2010.2Test
https://doi.org/10.1016/j.sleep.2021.03.003Test
https://doi.org/10.1136/bmj.n972Test
https://doi.org/10.1097/MCP.0000000000000496Test
https://doi.org/10.1111/ijd.15341Test
https://doi.org/10.1007/s11136-021-02804-6Test
https://doi.org/10.2522/ptj.20100330Test

View record in BASE

9

Mild Cognitive Impairment: Current Aspects of Diagnosis and Treatment

المؤلفون: A. A. Pilipovich, O. V. Vorob’eva

المصدر: Neuroscience and Behavioral Physiology. 51:1033-1039

مصطلحات موضوعية: medicine.medical_specialty, business.industry, General Neuroscience, medicine, Audiology, Current (fluid), Cognitive impairment, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::91f7e67901fb251856304869e2e3ee22Test
https://doi.org/10.1007/s11055-021-01162-7Test

10

Effect of Bone Marrow Allotransplantation on Neurotransmitter Structures of Lymph Nodes

المؤلفون: V. O. Romanov, L. A. Lyubovtseva, O. V. Vorob'eva, L. P. Romanova

المصدر: Journal of Anatomy and Histopathology. 10:54-62

مصطلحات موضوعية: Chemistry, Degranulation, Context (language use), Mononuclear phagocyte system, Molecular biology, 03 medical and health sciences, 0302 clinical medicine, medicine.anatomical_structure, Immune system, Cervical lymph nodes, 030220 oncology & carcinogenesis, medicine, Serotonin, Bone marrow, Lymph, 030217 neurology & neurosurgery

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::71df00a661ebb785864240c58fb6989dTest
https://doi.org/10.18499/2225-7357-2021-10-1-54-62Test

تنقيح النتائج